Table 1 Estimated average monthly rates of adverse events per 100,000 patients in two time periods
From: Rosiglitazone use and associated adverse event rates in Canada between 2004 and 2010
April 2004 - October 2007 | November 2007 - December 2010 | |||||
|---|---|---|---|---|---|---|
Average | Range | 95% CI | Average | Range | 95% CI | |
Adverse events | 13.4 | 2.3-27.3 | 8.6-20.8 | 5.7 | 0.0-12.5 | 2.4-13.6 |
Serious adverse events | 6.0 | 0.6-21.5 | 3.1-11.5 | 3.4 | 0.0-8.7 | 1.1-10.6 |
Cardiac adverse events | 2.3 | 0.0-9.4 | 0.8-6.5 | 2.2 | 0.0-6.6 | 0.5-8.9 |